1. Home
  2. PSO vs RGEN Comparison

PSO vs RGEN Comparison

Compare PSO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pearson Plc

PSO

Pearson Plc

N/A

Current Price

$13.14

Market Cap

8.2B

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$119.94

Market Cap

8.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PSO
RGEN
Founded
1844
1981
Country
United Kingdom
United States
Employees
17116
N/A
Industry
Books
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.1B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
PSO
RGEN
Price
$13.14
$119.94
Analyst Decision
Strong Buy
Buy
Analyst Count
1
11
Target Price
N/A
$173.09
AVG Volume (30 Days)
996.0K
771.2K
Earning Date
01-01-0001
05-27-2026
Dividend Yield
2.49%
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.86
Revenue
N/A
$141,236,000.00
Revenue This Year
$5.90
$14.11
Revenue Next Year
$4.88
$14.71
P/E Ratio
$14.05
$141.40
Revenue Growth
N/A
35.10
52 Week Low
$12.02
$102.97
52 Week High
$16.70
$175.77

Technical Indicators

Market Signals
Indicator
PSO
RGEN
Relative Strength Index (RSI) 57.27 32.30
Support Level $12.92 $113.07
Resistance Level $13.34 $132.51
Average True Range (ATR) 0.22 6.52
MACD 0.07 -0.11
Stochastic Oscillator 82.74 6.37

Price Performance

Historical Comparison
PSO
RGEN

About PSO Pearson Plc

UK-listed Pearson is a testing and educational provider. Pearson's primary operations are in assessment and qualification testing and higher education, but they also provide English education and testing, virtual learning, prehiring testing and screening, and upskilling/reskilling. The company divested noncore businesses, including the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: